---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-008229"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:04:29.543149+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma enters $8M equity purchase agreement with Alumni Capital, with $4M minimum purchase commitment

## Summary
- Agreement allows Quoin to sell up to $8M of ADSs to Alumni Capital at discounts of 2% to 10% to market.
- Minimum purchase of $4M required during the 90-day commitment period, extendable by 90 days.
- Per-purchase limit typically $500k; floor price $1.00; commitment fee up to $240k in ADSs.
- Shareholder approval must be obtained by April 30, 2024; else Quoin may terminate agreement.

## SEC filing metadata
- accession: 0001104659-24-008229
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/0001104659-24-008229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/tm244426d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-008229
- JSON: https://secwatch.observer/filing/0001104659-24-008229.json
- Plain text: https://secwatch.observer/filing/0001104659-24-008229.txt

## Key facts
- Material Agreements
  Quoin Pharmaceuticals, Ltd. entered into Purchase Agreement with Alumni Capital LP valued at up to $8,000,000 (effective 2024-01-25).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Alumni Capital LP
  - Value: up to $8,000,000
  - Effective: 2024-01-25
  source text: On January 25, 2024, Quoin Pharmaceuticals Ltd. (the “Company” or “we”) entered into a Purchase Agreement (the “Purchase Agreement”) with Alumni Capital LP (“Alumni”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/0001104659-24-008229-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.